documents: FDA-2011-D-0652-0033
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-D-0652-0033 | FDA | FDA-2011-D-0652 | The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]; Guidance for Industry and Food and Drug Administra tion Staff | Other | Guidance | 2014-07-28T04:00:00Z | 2014 | 7 | 2014-07-28T04:00:00Z | 2024-11-12T05:27:17Z | 1 | 0 | 09000064817e7e24 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref